EN2 and glioblastoma: To further explore the drug resistance of GBM cells with the silence of EN2 in vivo, we subcutaneously implanted GBM cell‐shNC and GBM cell‐shEN2 into nude mice and administered TMZ treatment, regularly monitoring the size of the tumour.